|
RPAP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.97232999999963E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.6775999999451E-06 |
| Normal-vs-Stage2 |
6.839900E-02 |
| Normal-vs-Stage3 |
4.531600E-02 |
| Normal-vs-Stage4 |
1.048190E-01 |
| Stage1-vs-Stage2 |
5.675800E-01 |
| Stage1-vs-Stage3 |
4.560400E-01 |
| Stage1-vs-Stage4 |
3.373800E-01 |
| Stage2-vs-Stage3 |
9.515800E-01 |
| Stage2-vs-Stage4 |
6.761800E-01 |
| Stage3-vs-Stage4 |
7.115400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.47509999999895E-05 |
| Normal-vs-AfricanAmerican |
5.169200E-04 |
| Normal-vs-Asian |
9.940200E-01 |
| Caucasian-vs-AfricanAmerican |
7.983400E-01 |
| Caucasian-vs-Asian |
1.878770E-01 |
| AfricanAmerican-vs-Asian |
1.790640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.66339999996268E-07 |
| Normal-vs-Female |
3.562600E-01 |
| Male-vs-Female |
4.26590000000004E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.483900E-03 |
| Normal-vs-Extreme_Weight |
3.27430000002238E-06 |
| Normal-vs-Obese |
5.018700E-04 |
| Normal-vs-Extreme_Obese |
2.741400E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.315800E-01 |
| Normal_Weight-vs-Obese |
9.423200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.802400E-01 |
| Extreme_Weight-vs-Obese |
4.203200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.267800E-01 |
| Obese-vs-Extreme_Obese |
6.169200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.119600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.815400E-03 |
| Normal-vs-Age(61-80Yrs) |
5.75419999981897E-07 |
| Normal-vs-Age(81-100Yrs) |
3.11109999995285E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.198800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.744000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.117700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.006350E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.516160E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.110800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.72650000005181E-06 |
| Normal-VS-Type2 PRCC |
3.56420000000579E-05 |
| Normal-VS-KIRP CIMP |
9.608600E-01 |
| Normal-VS-Unclassified PRCC |
2.166800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.054200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.138000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.673000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.546000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.081900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.594000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.02719999997658E-06 |
| Normal-vs-N1 |
7.787600E-01 |
| Normal-vs-N2 |
5.463800E-01 |
| N0-vs-N1 |
4.021600E-03 |
| N0-vs-N2 |
4.842800E-01 |
| N1-vs-N2 |
5.481600E-01 |
|
|
